|
Market Closed -
Boerse Muenchen
23:44:22 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.3620 EUR | 0.00% |
|
0.00% | +21.68% |
| 09-02 | Nicox S.A. Announces Appointment of Doug Hubatsch as Chief Scientific Advisor | CI |
| 08-27 | The FDA will issue its decision on Nicox's NCX 470 by the end of next April |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ALCOX Stock
- NXOA Stock
- Consensus Nicox SA
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
